Error: Could not add to watchlist. X

Pharmos Corp

+ Watchlist
PHA1:GR
Ticker Delisted
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.04
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Pharmos Corporation is a bio-pharmaceutical company that discovers and develops new drugs to treat a range of neuroinflammatory disorders. The company has a portfolio of drug candidates under development. Pharmos's main product, dexanabinol, is a synthetic non-psychotropic cannabinoid currently in late stage clinical development for the treatment of traumatic brain injury (TBI).
ADDRESS
99 Wood Avenue South
Suite 302
Iselin, NJ 08830
United States
PHONE
1-732-452-9556
  • Robert F Johnston
    Chairman
  • Eric W Fangmann
    Acting President/Acting CFO
Show More